Table 3.

Resources included in identified estimates of the per-patient annual direct medical cost of spinal muscular atrophy

Author (year)	Inpatient care	Outpatient care	Emergency care	Prescription drugs	OTC drugs	Medical devices and aids	Co-payments
Armstrong et al. (2016) [19]	×	×	NR	×
Chambers et al. (2020) [25]	×	×	×	×	×	×	×
Darbà (2020) [24]	×	×	×
Droege et al. (2019) [18]	×	×	NR	×
Klug et al. (2016) [20]	×	×	NR	×		×
López-Bastida et al. (2017) [13]	×	×	×	×		×
Marcellusi et al. (2019) [22]	×	×				×	×
Peña-Longobardo et al. (2020) [26]	×	×	×	×	NR	×
Tan et al. (2019) [21]	×	×	×	×
Zuluaga-Sanchez et al. (2019) [23]	×	×	×	×		×

NR not reported (i.e., that the information was not provided, but that the specific resource category could have been included in the estimation, for example as part of higher level cost categories), OTC over-the-counter